Blood count analysis showed equal proportions of leukocytes across the mutational spectrum of the MDS cohort but indicated increased ring sideroblasts (RS) and anemia specifically in SF3B1-mutated MDS (Supplementary Fig. 1B), which is consistent with the current WHO consensus classification of MDS-RS45,46. Here, SF3B1 is linked to myelodysplastic syndrome.